In the context of GBM, the most studied neurotrophins are NGF [44] and NT-3 [45], whose interaction with its specific receptor present on the surface of tumor cells, Tropomyosin-related kinase A and C (TrkA) [46] (TrkC), respectively, could contribute to tumor aggressiveness. The gene discussed is NGF; the disease is glioblastoma.